{
  "documentMetadata": {
    "title": "Septic Arthritis - Staph. aureus",
    "lastUpdated": "2025-02-09",
    "sourceFile": "Arthritis, Septic, Staph. aureus.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Documented septic arthritis, synovial fluid WBC > 25,000 (>50,000 more specific).",
        "Acromioclavular or sacroiliac joint septic arthritis often due to Staph. aureus.",
        "Gram-positive cocci in clusters on Gram stain and/or isolation of Staph. aureus in synovial fluid or blood culture.",
        "Risk factors include rheumatoid arthritis, diabetes, injection drug use, skin infection.",
        "For joint prosthesis see recommendations for Prosthetic Joint Infection."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Staphylococcus aureus"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "procedure",
      "procedureData": {
        "name": "Drainage or debridement",
        "notes": "In addition to antimicrobial therapy drainage or debridement should always be performed by needle aspiration (repeated as needed), arthroscopy, or arthrotomy."
      }
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Specific antimicrobial therapy for initial therapy (see comments regarding duration):"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "appliesTo": {
              "description": "MRSA"
            },
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "route": "IV",
                "frequency": "q8-12h"
              }
            ],
            "durationDetail": {
              "fixedDuration": "2-3 weeks"
            },
            "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "appliesTo": {
              "description": "MSSA"
            },
            "components": [
              {
                "drug": "Nafcillin",
                "dose": "1.5-2 gm",
                "route": "IV",
                "frequency": "q4h"
              },
              {
                "drug": "Oxacillin",
                "dose": "1.5-2 gm",
                "route": "IV",
                "frequency": "q4h",
                "connector": "or"
              },
              {
                "drug": "Flucloxacillin",
                "dose": "2 gm",
                "route": "IV",
                "frequency": "q6h",
                "connector": "or"
              }
            ],
            "durationDetail": {
              "fixedDuration": "2-3 weeks"
            }
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "appliesTo": {
              "description": "MSSA"
            },
            "components": [
              {
                "drug": "Cefazolin",
                "dose": "2 gm",
                "route": "IV",
                "frequency": "q8h"
              }
            ],
            "durationDetail": {
              "fixedDuration": "2-3 weeks"
            }
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "MRSA"
        },
        "components": [
          {
            "drug": "Daptomycin",
            "dose": "6 mg/kg",
            "route": "IV",
            "frequency": "q24h"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "MRSA"
        },
        "components": [
          {
            "drug": "Linezolid",
            "dose": "600 mg",
            "frequency": "q12h",
            "route": "po/IV"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "MSSA, patient with type 1 hypersensitivity to beta-lactams or with significant adverse reaction"
        },
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "15-20 mg/kg",
            "route": "IV",
            "frequency": "q8-12h"
          }
        ],
        "durationDetail": {
          "fixedDuration": "2-3 weeks"
        },
        "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "MSSA, patient with type 1 hypersensitivity to beta-lactams or with significant adverse reaction"
        },
        "components": [
          {
            "drug": "Daptomycin",
            "dose": "6 mg/kg",
            "route": "IV",
            "frequency": "q24h"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "MSSA, patient with type 1 hypersensitivity to beta-lactams or with significant adverse reaction"
        },
        "components": [
          {
            "drug": "Linezolid",
            "dose": "600 mg",
            "frequency": "q12h",
            "route": "po/IV"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Possible oral regimens provided in vitro susceptibility is confirmed, include Clindamycin 600 mg po q8h OR ([TMP-SMX 4-5 mg/kg po (Trimethoprim component) bid OR Levofloxacin 750 mg po once daily] + Rifampin 600 mg po q24h), OR Linezolid 600 mg po q12h OR Cephalexin 500 mg po q6h"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Consider treatment for 4 weeks in patients with septic arthritis complicated by bacteremia.",
        "Reference: Curr Rheumatol Rep 15:332, 2013",
        "Retrospective study of Clindamycin and Cephalexin in children found either to be efficacious (Clin Microbiol Infect 18:582, 2012)."
      ]
    }
  ]
}
